FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended to predict the exacerbation of gastroduodenal ulcer associated with Helicobacter pylori. Determine biochemical parameters of blood and PAF (platelet activating factor) and LT (leukotrienes) parameters. With an increase in the concentration in the gastric mucosa of the platelet activation factor from 9.12 pg/mg protein or more, leukotrienes from 4.68 ng/mg and more, correlating with the contamination of the mucous membrane with Helicobacter pylori, predict an exacerbation of gastroduodenal ulcer.
EFFECT: method makes it possible to improve the accuracy of the prediction of exacerbations of gastroduodenal ulcer associated with Helicobacter pylori.
1 cl, 12 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF ULCER CICATRISATION RATE IN PATIENTS WITH UNCOMPLICATED GASTRIC ULCER | 2014 |
|
RU2572725C2 |
| METHOD FOR TREATING ULCEROUS GASTRIC AND DUODENAL DISEASE | 1999 |
|
RU2189215C2 |
| METHOD FOR ERADICATION OF GASTRIC AND DUODENAL HELICOBACTER PYLORI | 2006 |
|
RU2319523C2 |
| METHOD FOR TREATING GASTRIC AND DUODENAL PEPTIC ULCERS | 1999 |
|
RU2147877C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF STOMACH- OR DUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI | 2003 |
|
RU2269132C2 |
| METHOD OF MONOTHERAPY OF PYLORIC HELICOBACTERIOSIS | 1997 |
|
RU2185827C2 |
| METHOD FOR PREDICTION OF GASTRIC ULCER CICATRISATION RATE | 2008 |
|
RU2406448C2 |
| METHOD OF GASTRIC ULCER TREATMENT, ASSOCIATED WITH HELICOBACTER INFECTION | 2007 |
|
RU2365371C1 |
| METHOD FOR HELICOBACTER PYLORI ERADICATION OF GASTRODUODENAL ZONE | 2014 |
|
RU2545687C1 |
| METHOD FOR ASSESSING THE SEVERITY OF GASTRIC ULCER WITH ULCER LOCALIZATION IN THE ANTRUM ASSOCIATED WITH HELICOBACTER PYLORI AND EPSTEIN-BARR VIRUS | 2021 |
|
RU2756418C1 |
